Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Reorganizes Around Key R&D Areas As Lepore Exits

Therapy Area Research Units Created

19 Sep 2023

• By Andrew McConaghie

New GSK House — • Source: GSK

Related Content

GSK’s Ojjaara Scores Myelofibrosis Nod After Round-The-World Journey

18 Sep 2023

Barron Signs Off With Notes On GSK Culture Change, Tease On RSV Vaccine Results

28 Jul 2022

Related Companies

GSK plc

Additional Topics

Executive Changes Leadership Companies Research & Development BioPharmaceutical

More from Executives On The Move

More from Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.